Vineet Laboratories Limited (VINEETLAB) Share Price
NSE · Basic Materials · Chemicals · ISIN INE505Y01010
Key metrics
- Market Cap
- ₹73 Cr
- P/E Ratio
- 65.45
- EPS
- -7.5
- Book Value
- 23.74
- P/B Ratio
- 1.6
- ROE
- 2.44%
- ROCE
- 6.67%
- Debt / Equity
- 0.99
- Net Margin
- 1.87%
- Revenue Growth
- -20.79%
- Profit Growth
- 105.5%
- Dividend Yield
- —
- 52W High
- ₹49.99
- 52W Low
- ₹27.96
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Vineet Laboratories Limited
Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals primarily in India. The company offers intermediates of Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine, and other API intermediates. It also provides fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside, n-butyl lithium, 4-nitrophenyl phosphate disodium salt, 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside, 5-acetyl thiophene-2-carboxilic acid, 4-chlorobutyryl chloride, n-butyl magnesium chloride, 3-furaldehyde, 3-bromofuran, n-butylnitrite, ethyldiazo acetate, phenylboronic acid, 6-aminouracil, and 1-methyl-imidazole-2-carboxaldehyde. The company was incorporated in 2016 and is based in Hyderabad, India.
- Headquarters
- Hyderabad, India
- Promoter Holding
- 37.34%
The full Vineet Laboratories Limited analysis
Create a free account to open the complete VINEETLAB deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.